April 12, 2022 – The Minneapolis Heart Institute Foundation (MHIF) has announced the first presentation and simultaneous publication of two-year outcomes from the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI) showing improvements in survival in 2021 relative to 2020. However, mortality remains high in unvaccinated patients with STEMI and COVID-19 infection.

April 12, 2022 –  iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announces the results of three clinical research studies presented at The American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC.22). The new clinical evidence:

April 12, 2022 — The American College of Cardiology has issued an expert consensus decision pathway for the evaluation and management of adults with key cardiovascular consequences of COVID-19. The document discusses myocarditis and other types of myocardial involvement, patient-centered approaches for long COVID and guidance on resumption of exercise following COVID-19.

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib).

April 12, 2022 — Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm disorders, according to a new study from investigators in the Smidt Heart Institute at Cedars-Sinai.

April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use. The platform is indicated to guide and support a guidewire during access of the peripheral or coronary vasculature, allow for wire exchanges, and provide a conduit for delivery of saline solutions or diagnostic contrast agents. 

Stollery Cardiac Program Virtual Symposium "Fetal-Perinatal-Neonatal Cardiac Continuum-Getting It Right from the Start!"

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.

April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after seeing a patient, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now